Medindia LOGIN REGISTER
Medindia

Side effect(s) of Glecaprevir and Pibrentasvir


Review the side-effects of Glecaprevir and Pibrentasvir as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.

If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.
The side effects of the fixed-dose combination of glecaprevir and pibrentasvir are as follows:
Headache
• Fatigue
• Nausea
• Diarrhea
• Increased bilirubin levels
• Intense itching of the skin

Other Precautions :

• In case of overdosage, the patient should be monitored strictly for the signs and symptoms.
• It is necessary to initiate an appropriate symptomatic treatment at the earliest.

Drug Name : Glecaprevir and Pibrentasvir

Glecaprevir and Pibrentasvir generic Glecaprevir (a HCV NS3/4A protease inhibitor) and pibrentasvir (HCV NS5A phosphoprotein inhibitor) combination is used for the treatment of all genotypes (1-6) of chronic hepatitis C virus infection either without cirrhosis or with compensated early stage cirrhosis in adults. Hepatitis C is a viral disease that causes swelling of the liver which leads to reduced liver function, cirrhosis, liver failure or in some cases death. This fixed-dose combination is also used to treat adult patients suffering from HCV genotype infection 1 who have been already treated with either HCV NS3/4A protease inhibitors or HCV NS5A inhibitors but not in combination. .


Advertisement